GlobeNewswireUnresolved
GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS
Investors who lost money in GRAL after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.